Susan Buchbinder, MD
Professor
Medicine
School of Medicine

Publications (231)

Top publication keywords:
TenofovirDisease Transmission, InfectiousAnti-HIV AgentsHomosexuality, MalePost-Exposure ProphylaxisOrganophosphonatesHIV InfectionsHIV-1DoxycyclinePre-Exposure ProphylaxisMedication AdherenceChemopreventionAIDS VaccinesAnti-Retroviral AgentsSexually Transmitted Diseases

• Sexually transmitted infections after implementation of doxycycline postexposure prophylaxis.
  Sexually transmitted infections 2026 Scott HM, Roman J, Spinelli M, Bena J, Torres T, Glidden D, Buchbinder S
• Sustained Effectiveness of Doxycycline Post-Exposure-Prophylaxis in a Large Sexual Health Clinic Over 96 Weeks: An Interrupted Time Series Analysis.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 Spinelli MA, Heise MJ, Roman J, Bena J, Barry MP, Buchbinder SP, Scott HM
• Acceptability and use of doxyPEP among cisgender men who have sex with men, transgender women and non-binary persons assigned male sex at birth: results from a national online survey from the USA.
  Sexually transmitted infections 2026 Gistand NL, Torres TS, Celum C, Luetkemeyer A, Buchbinder S, Scott HM
• Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-Term Pre-exposure Prophylaxis Adherence for US Men Who Have Sex With Men in Pilot RCT.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 Spinelli MA, Ewart LD, Ross EJ, Heise MJ, Buccheri R, Moreira C, Mahuvakar S, Glidden DV, Amico KR, Arnold E, Rodrigues W, Okochi H, Manuel J, Handley M, Buchbinder SP, Carrico A, Gandhi M
• The Urgency of Now: Congenital Syphilis in the Doxycycline Post-exposure Prophylaxis Era.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 Spinelli MA, Scott HM, Buchbinder SP

Show all (226 more) Hide

• CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.
  Topics in antiviral medicine 2026 Buchbinder SP, Liu AY
• On-Demand Dosing of HIV Preexposure Prophylaxis for Women: Has Their Time Finally Come?
  The Journal of infectious diseases 2026 Buchbinder SP, Anderson PL
• Evidence-Informed Provision of Doxycycline Postexposure Prophylaxis for Prevention of Bacterial Sexually Transmitted Infections.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 Dombrowski JC, Donnell D, Grabow C, Cohen SE, Cannon CA, Brown CE, Buchbinder SP, Celum C, Luetkemeyer AF
• Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.
  The lancet. HIV 2025 Buchbinder SP, Spinosa Guzman S, Sanchez J, Willems W, Stieh DJ, van Duijn J, van Rosmalen MGM, Hendriks J, Nijs S, Lavreys L, Paez CA, Grinzstejn B, Hutter J, Mann P, Sierra Madero JG, Cahn P, …
• Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320.
  EBioMedicine 2025 Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, Benkeser D, Zou R, Hural J, Hyrien O…
• Preexposure Prophylaxis for HIV: Updated Recommendations From the 2024 International Antiviral Society-USA Panel.
  JAMA 2025 Landovitz RJ, Molina JM, Buchbinder SP, International Antiviral Society–USA (IAS-USA) Panel
• Implementation Barriers and Facilitators in a Pilot Long-Acting HIV Treatment Intervention for Trans Women Living with HIV in San Francisco.
  AIDS patient care and STDs 2025 Wilson EC, Myers J, Muñoz Acosta G, Sicro S, Schaeffer E, Alleyne CD, Diaz A, Walker N, Vinson J, Buchbinder S, Scott H, Liu A
• Developing a Novel Mobile App to Support HIV Testing and Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Formative and Technical Pilot Study.
  JMIR human factors 2025 Liu AY, Torres TS, Alleyne CD, Vinson J, Bojan K, Serrano PA, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Muessig KE, Buchbinder SP, Sullivan P, Hightow-Weidman LB, Scott H
• CROI 2025: global epidemiology and prevention of HIV and other sexually transmitted diseases.
  Topics in antiviral medicine 2025 Buchbinder SP, Liu AY
• Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.
  JAMA network open 2025 Andrews LIB, Halloran ME, Neuzil KM, van der Laan L, Huang Y, Andriesen J, Patel M, Fisher LH, Janes H, Rouphael N, Walsh SR, Theodore DA, Tieu HV, Sobieszczyk M, El Sahly HM, Baden LR, Falsey AR, …
• An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP - Essential or Irrelevant?
  The New England journal of medicine 2025 Jatt LP, Mgodi NM, Buchbinder SP, Gray GE, Kublin JG
• Innovation in Providing Equitable Pre-exposure Prophylaxis Services in the United States: Expanding Access in Nontraditional Settings.
  Journal of acquired immune deficiency syndromes (1999) 2025 Mantell JE, Bauman LJ, Bonett S, Buchbinder S, Hoffman S, Storholm ED, McCoy K, Rael CT, Cowan E, Gonzalez-Argoti T, Safa H, Scott H, Murtaugh KL, Wilson NL, Liu A
• Language Justice in Implementation Science: Experiences Working With Latinxs to End the HIV Epidemic.
  Journal of acquired immune deficiency syndromes (1999) 2025 Rodriguez-Diaz CE, Jaramillo J, Santiago-Rivera Y, Harkness A, Cantos VD, Liu A, Buchbinder S, Saldana CS, Gonzalez K, Malavé-Rivera SM, Reyes N, Vinson J, Scott JY, Lanzi RG, Hidalgo B
• Pre-Exposure Prophylaxis Awareness and Demand Creation: Overlooked Populations and Opportunities to Move Forward.
  Journal of acquired immune deficiency syndromes (1999) 2025 McCoy K, Mantell JE, Deiss R, Liu A, Bauman LJ, Bonner CP, Vinson J, Buchbinder S
• Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.
  The Lancet. Infectious diseases 2025 Luetkemeyer AF, Donnell D, Cohen SE, Dombrowski JC, Grabow C, Haser G, Brown C, Cannon C, Malinski C, Perkins R, Nasser M, Lopez C, Suchland RJ, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, …
• Active-Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo.
  Statistics in medicine 2025 Gao F, Janes H, Buchbinder S, Donnell D
• Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends.
  JAMA internal medicine 2025 Sankaran M, Glidden DV, Kohn RP, Nguyen TQ, Bacon O, Buchbinder SP, Gandhi M, Havlir DV, Liebi C, Luetkemeyer AF, Nguyen JQ, Roman J, Scott H, Torres TS, Cohen SE
• Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.
  JAMA 2025 Gandhi RT, Landovitz RJ, Sax PE, Smith DM, Springer SA, Günthard HF, Thompson MA, Bedimo RJ, Benson CA, Buchbinder SP, Crabtree-Ramirez BE, Del Rio C, Eaton EF, Eron JJ, Hoy JF, Lehmann C, Molina JM, …
• Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease.
  Nature communications 2024 Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, …
• Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.
  EBioMedicine 2024 Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, Benkeser D, Zou R, Hural J, Hyrien O…
• Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration.
  AIDS care 2024 Velloza J, Liu AY, Katz AWK, van der Straten A, Siegler AJ, Scott H, Wilde G, Lockard A, Christie RH, Buchbinder SP
• Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease.
  medRxiv : the preprint server for health sciences 2024 Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, …
• Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.
  The Lancet. Infectious diseases 2024 Gray GE, Mngadi K, Lavreys L, Nijs S, Gilbert PB, Hural J, Hyrien O, Juraska M, Luedtke A, Mann P, McElrath MJ, Odhiambo JA, Stieh DJ, van Duijn J, Takalani AN, Willems W, Tapley A, Tomaras GD, Van …
• CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.
  Topics in antiviral medicine 2024 Liu AY, Buchbinder SP
• Is HIV epidemic control by 2030 realistic?
  The lancet. HIV 2024 Beyrer C, Tomaras GD, Gelderblom HC, Gray GE, Janes HE, Bekker LG, Millett G, Pantaleo G, Buchbinder S, Corey L
• Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users.
  AIDS (London, England) 2024 Martinson T, Montoya R, Moreira C, Kuncze K, Sassaman K, Heise MJ, Glidden DV, Amico KR, Arnold EA, Buchbinder SP, Ewart LD, Carrico A, Wang G, Okochi H, Scott HM, Gandhi M, Spinelli MA
• Impact of HLA class I functional divergence on HIV control.
  Science (New York, N.Y.) 2024 Viard M, O'hUigin C, Yuki Y, Bashirova AA, Collins DR, Urbach JM, Wolinsky S, Buchbinder S, Kirk GD, Goedert JJ, Michael NL, Haas DW, Deeks SG, Walker BD, Yu X, Carrington M
• New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact?
  JAMA 2023 Liu AY, Scott HM, Buchbinder SP
• CROI 2023: Epidemiologic Trends and Prevention for HIV and Other Sexually Transmitted Infections.
  Topics in antiviral medicine 2023 Liu AY, Buchbinder SP
• Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
  The New England journal of medicine 2023 Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C, …
• Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
  JAMA 2023 Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Günthard HF, Molina JM, Jacobsen DM, Saag MS
• Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens.
  EBioMedicine 2022 Huang Y, Zhang Y, Seaton KE, De Rosa S, Heptinstall J, Carpp LN, Randhawa AK, McKinnon LR, McLaren P, Viegas E, Gray GE, Churchyard G, Buchbinder SP, Edupuganti S, Bekker LG, Keefer MC, Hosseinipour …
• Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Spinelli MA, Le Tourneau N, Glidden DV, Hsu L, Hickey MD, Imbert E, Arreguin M, Jain JP, Oskarsson JJ, Buchbinder SP, Johnson MO, Havlir D, Christopoulos KA, Gandhi M
• Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men.
  AIDS and behavior 2022 Buchbinder SP, Siegler AJ, Coleman K, Vittinghoff E, Wilde G, Lockard A, Scott H, Anderson PL, Laborde N, van der Straten A, Christie RH, Marlborough M, Liu AY
• Effect of Social Determinants of Health on Uncontrolled Human Immunodeficiency Virus (HIV) Infection Among Persons With HIV in San Francisco, California.
  Open forum infectious diseases 2022 Melo JS, Hessol NA, Pipkin S, Buchbinder SP, Hsu LC
• COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
  Lancet (London, England) 2022 Buchbinder SP, McElrath MJ, Dieffenbach C, Corey L
• SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.
  AIDS (London, England) 2021 Spinelli MA, Brown LB, Glidden DV, Hunter K, Martin-Tuite P, Zheng J, Sera C, Havlir D, Buchbinder SP, Gandhi M
• Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco.
  American journal of preventive medicine 2021 Bacon OML, Coffey SC, Hsu LC, Chin JCS, Havlir DV, Buchbinder SP
• Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
  The New England journal of medicine 2021 Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, …
• CROI 2021: Epidemiologic Trends in the HIV and SARS-CoV-2 Pandemics and HIV Prevention Research.
  Topics in antiviral medicine 2021 Buchbinder S, Liu A
• Sensitivity and Specificity of the National Death Index for Multiple Causes of Death in People With HIV.
  Public health reports (Washington, D.C. : 1974) 2021 Schwarcz S, Hessol NA, Spinelli MA, Hsu LC, Wlodarczyk D, Tulsky J, Newman MD, Buchbinder SP
• Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
  JAMA 2020 Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA
• HLA tapasin independence: broader peptide repertoire and HIV control.
  Proceedings of the National Academy of Sciences of the United States of America 2020 Bashirova AA, Viard M, Naranbhai V, Grifoni A, Garcia-Beltran W, Akdag M, Yuki Y, Gao X, O'hUigin C, Raghavan M, Wolinsky S, Bream JH, Duggal P, Martinson J, Michael NL, Kirk GD, Buchbinder SP, Haas D…
• Use of adenovirus type-5 vectored vaccines: a cautionary tale.
  Lancet (London, England) 2020 Buchbinder SP, McElrath MJ, Dieffenbach C, Corey L
• Understanding PrEP Persistence: Provider and Patient Perspectives.
  AIDS and behavior 2020 Laborde ND, Kinley PM, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, Buchbinder SP
• Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.
  Scientific reports 2020 Palli R, Seaton KE, Piepenbrink MS, Hural J, Goepfert PA, Laher F, Buchbinder SP, Churchyard G, Gray GE, Robinson HL, Huang Y, Janes H, Kobie JJ, Keefer MC, Tomaras GD, Thakar J
• The importance of PrEP persistence in preventing HIV infections on PrEP.
  Journal of the International AIDS Society 2020 Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP
• Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 Spinelli MA, Buchbinder SP
• Virtual CROI 2020: Highlights of Epidemiology, Public Health, and Prevention Research.
  Topics in antiviral medicine 2020 Buchbinder SP, Liu AY
• Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States.
  Journal of the International AIDS Society 2020 Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP
• Getting to Zero San Francisco: A Collective Impact Approach.
  Journal of acquired immune deficiency syndromes (1999) 2019 Buchbinder SP, Havlir DV
• Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics.
  AIDS (London, England) 2019 Scott HM, Spinelli M, Vittinghoff E, Morehead-Gee A, Hirozawa A, James C, Hammer H, Liu A, Gandhi M, Buchbinder S
• Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
  Journal of virology 2019 Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, Buchbinder SP, Keefer MC, DeJesus E, Novak …
• Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors.
  PloS one 2019 Janes H, Brown MD, Glidden DV, Mayer KH, Buchbinder SP, McMahan VM, Schechter M, Guanira J, Casapia M
• Ending AIDS in the United States-If Not Now, When?
  JAMA internal medicine 2019 Havlir DV, Buchbinder SP
• Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a US city.
  AIDS (London, England) 2019 Spinelli MA, Hessol NA, Schwarcz S, Hsu L, Parisi MK, Pipkin S, Scheer S, Havlir D, Buchbinder SP
• Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.
  AIDS research and human retroviruses 2019 Spinelli MA, Glidden DV, Anderson PL, Gandhi M, McMahan VM, Defechereux P, Schechter M, Veloso VG, Chariyalertsak S, Guanira JV, Bekker LG, Buchbinder SP, Grant RM
• STIs: an unintended consequence of improved sexual health?
  The lancet. HIV 2019 Scott HM, Buchbinder SP
• Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
  Journal of acquired immune deficiency syndromes (1999) 2019 Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY
• Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Liu AY, Vittinghoff E, von Felten P, Rivet Amico K, Anderson PL, Lester R, Andrew E, Estes I, Serrano P, Brothers J, Buchbinder S, Hosek S, Fuchs JD
• The aspirational necessity of HIV prevention.
  Journal of the International AIDS Society 2019 Corey L, Gray GE, Buchbinder SP
• CROI 2019: advances in HIV prevention and plans to end the epidemic.
  Topics in antiviral medicine 2019 Buchbinder SP, Liu AY
• High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application.
  Sexually transmitted diseases 2019 Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Coleman K, Buchbinder SP
• Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project.
  AIDS (London, England) 2019 Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Okochi H, Kuncze K, Mehrotra M, Defechereux P, Buchbinder SP, Grant RM, Gandhi M
• Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort.
  Open forum infectious diseases 2019 Clemenzi-Allen A, Neuhaus J, Geng E, Sachdev D, Buchbinder S, Havlir D, Gandhi M, Christopoulos K
• Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network.
  Open forum infectious diseases 2019 Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Gonzalez R, Morehead-Gee A, Gandhi M, Buchbinder SP
• Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System.
  Journal of acquired immune deficiency syndromes (1999) 2018 Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Gandhi M, Buchbinder SP
• Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.
  JAMA 2018 Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA
• Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM
• Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network.
  Open forum infectious diseases 2018 Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Buchbinder SP
• CROI 2018: Epidemic Trends and Advances in HIV Prevention.
  Topics in antiviral medicine 2018 Buchbinder SP, Liu AY
• Maximizing the Benefits of HIV Preexposure Prophylaxis.
  Topics in antiviral medicine 2018 Buchbinder SP
• Degree of Housing Instability Shows Independent "Dose-Response" With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus.
  Open forum infectious diseases 2018 Clemenzi-Allen A, Geng E, Christopoulos K, Hammer H, Buchbinder S, Havlir D, Gandhi M
• A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis.
  AIDS patient care and STDs 2018 Fuchs JD, Stojanovski K, Vittinghoff E, McMahan VM, Hosek SG, Amico KR, Kouyate A, Gilmore HJ, Buchbinder SP, Lester RT, Grant RM, Liu AY
• Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project.
  Journal of acquired immune deficiency syndromes (1999) 2018 Tang EC, Vittinghoff E, Anderson PL, Cohen SE, Doblecki-Lewis S, Bacon O, Coleman ME, Buchbinder SP, Chege W, Kolber MA, Elion R, Shlipak M, Liu AY
• Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.
  PloS one 2018 Baxi SM, Vittinghoff E, Bacchetti P, Huang Y, Chillag K, Wiegand R, Anderson PL, Grant R, Greenblatt RM, Buchbinder S, Gandhi M, Liu AY
• HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
  PLoS medicine 2017 Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, …
• Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen.
  AIDS (London, England) 2017 Gandhi M, Murnane PM, Bacchetti P, Elion R, Kolber MA, Cohen SE, Horng H, Louie A, Kuncze K, Koss CA, Anderson PL, Buchbinder S, Liu A
• Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.
  Journal of acquired immune deficiency syndromes (1999) 2017 Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM
• Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
  PloS one 2017 Buchbinder SP, Grunenberg NA, Sanchez BJ, Seaton KE, Ferrari G, Moody MA, Frahm N, Montefiori DC, Hay CM, Goepfert PA, Baden LR, Robinson HL, Yu X, Gilbert PB, McElrath MJ, Huang Y, Tomaras GD, HIV …
• CROI 2017: HIV Epidemic Trends and Advances in Prevention.
  Topics in antiviral medicine 2017 Liu AY, Buchbinder SP
• Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
  The Journal of infectious diseases 2017 Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R, Finak G, Grove D, Shen M, Graham BS, Koup RA, Mulligan MJ, Koblin B, Buchbinder SP, Keefer MC,…
• International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status.
  Sexually transmitted diseases 2017 Truong HM, Mehrotra M, Montoya O, Lama JR, Guanira JV, Casapía M, Veloso VG, Buchbinder SP, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Grant RM
• Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.
  The lancet. HIV 2016 Gandhi M, Glidden DV, Mayer K, Schechter M, Buchbinder S, Grinsztejn B, Hosek S, Casapia M, Guanira J, Bekker LG, Louie A, Horng H, Benet LZ, Liu A, Grant RM
• Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes.
  AIDS and behavior 2016 Carlo Hojilla J, Koester KA, Cohen SE, Buchbinder S, Ladzekpo D, Matheson T, Liu AY
• CROI 2016: Hot Spots in HIV Infection and Advances in HIV Prevention.
  Topics in antiviral medicine 2016 Buchbinder SP, Liu AY
• Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study.
  AIDS and behavior 2016 Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S
• Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, McMahan V, Mayer KH, David B, Schechter M, Grinsztejn B, Guanira J, Grant RM
• Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
  JAMA internal medicine 2016 Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, Chege W, Postle BS, Matheson T, Amico KR, Liegler T, Rawlings MK, Trainor N, Blue RW, Estrada Y, Coleman ME, Cardenas G, …
• Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
  The Journal of infectious diseases 2015 Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, …
• HIV infection.
  Nature reviews. Disease primers 2015 Deeks SG, Overbaugh J, Phillips A, Buchbinder S
• Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.
  PloS one 2015 Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, Corey L, Mascola JR, Graham BS, Sobieszczyk ME…
• Authors' Reply: Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States.
  Journal of acquired immune deficiency syndromes (1999) 2015 Cohen SE, Vittinghoff E, Doblecki-Lewis S, Coleman M, Bacon O, Elion R, Kolber MA, Buchbinder S, Liu AY
• HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders.
  Nature medicine 2015 Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, Hural J, Corey L, Self SG, Buchbinder SP, McElrath MJ, O'Connell RJ, Paris RM, Rerks-Ngarm S, Nitayaphan S, Pitisuttihum P, Kaewkungwal …
• First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
  Open forum infectious diseases 2015 Fuchs JD, Frank I, Elizaga ML, Allen M, Frahm N, Kochar N, Li S, Edupuganti S, Kalams SA, Tomaras GD, Sheets R, Pensiero M, Tremblay MA, Higgins TJ, Latham T, Egan MA, Clarke DK, Eldridge JH, HVTN 090…
• Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role.
  Journal of acquired immune deficiency syndromes (1999) 2015 Carnegie NB, Goodreau SM, Liu A, Vittinghoff E, Sanchez J, Lama JR, Buchbinder S
• Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 Mulligan K, Glidden DV, Anderson PL, Liu A, McMahan V, Gonzales P, Ramirez-Cardich ME, Namwongprom S, Chodacki P, de Mendonca LM, Wang F, Lama JR, Chariyalertsak S, Guanira JV, Buchbinder S, Bekker LG…
• High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.
  Journal of acquired immune deficiency syndromes (1999) 2015 Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, Matheson T, Trainor N, Blue RW, Estrada Y, Coleman ME, Elion R, Castro JG, Chege W, Philip SS, Buchbinder S, Kolber MA, Liu …
• Client and provider perspectives on new HIV prevention tools for MSM in the Americas.
  PloS one 2015 Lippman SA, Koester KA, Amico KR, Lama JR, Martinez Fernandes N, Gonzales P, Grinsztejn B, Liu A, Buchbinder S, Koblin BA
• CROI 2015: Advances in HIV Testing and Prevention Strategies.
  Topics in antiviral medicine 2015 Buchbinder SP, Liu AY
• Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.
  Journal of acquired immune deficiency syndromes (1999) 2014 Liu A, Glidden DV, Anderson PL, Amico KR, McMahan V, Mehrotra M, Lama JR, MacRae J, Hinojosa JC, Montoya O, Veloso VG, Schechter M, Kallas EG, Chariyalerstak S, Bekker LG, Mayer K, Buchbinder S, Grant…
• Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities.
  Journal of acquired immune deficiency syndromes (1999) 2014 Mannheimer SB, Wang L, Wilton L, Van Tieu H, Del Rio C, Buchbinder S, Fields S, Glick S, Connor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH
• Low-level Viremia early in HIV infection.
  Journal of acquired immune deficiency syndromes (1999) 2014 Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH
• Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
  AIDS patient care and STDs 2014 Liu AY, Hessol NA, Vittinghoff E, Amico KR, Kroboth E, Fuchs J, Irvin R, Sineath RC, Sanchez T, Sullivan PS, Buchbinder SP
• Long-chain peer referral to recruit black MSM and black transgender women for an HIV vaccine efficacy trial.
  Journal of acquired immune deficiency syndromes (1999) 2014 Coombs A, McFarland W, Ick T, Fuqua V, Buchbinder SP, Fuchs JD
• Can male circumcision have an impact on the HIV epidemic in men who have sex with men?
  PloS one 2014 Goodreau SM, Carnegie NB, Vittinghoff E, Lama JR, Fuchs JD, Sanchez J, Buchbinder SP
• Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
  The Lancet. Infectious diseases 2014 Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker LG, Kallas EG, Schechter M, Guanira…
• A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
  PloS one 2014 Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Kobin BA, Wheeler D, Justman JE, …
• CROI 2014: New tools to track the epidemic and prevent HIV infections.
  Topics in antiviral medicine 2014 Buchbinder SP, Liu AY
• Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014 Sachdev DD, Stojanovski K, Liu AY, Buchbinder SP, Macalino GE
• Immunology. Immune activation with HIV vaccines.
  Science (New York, N.Y.) 2014 Fauci AS, Marovich MA, Dieffenbach CW, Hunter E, Buchbinder SP
• Over-the-counter human immunodeficiency virus self-test kits: time to explore their use for men who have sex with men in Brazil.
  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2014 Lippman SA, Veloso VG, Buchbinder S, Fernandes NM, Terto V, Sullivan PS, Grinsztejn B
• HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
  The Lancet. Infectious diseases 2014 Buchbinder SP, Glidden DV, Liu AY, McMahan V, Guanira JV, Mayer KH, Goicochea P, Grant RM
• LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.
  PLoS genetics 2014 Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH, Duggal P, Hussain S, Martinson J, Weintrob A, Kirk GD, Fellay J, Buchbinder SP, Goedert…
• Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.
  PLoS medicine 2014 Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, Buchbinder S
• Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.
  HIV medicine 2014 Marcus JL, Buisker T, Horvath T, Amico KR, Fuchs JD, Buchbinder SP, Grant RM, Liu AY
• Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).
  PloS one 2014 Liu AY, Yang Q, Huang Y, Bacchetti P, Anderson PL, Jin C, Goggin K, Stojanovski K, Grant R, Buchbinder SP, Greenblatt RM, Gandhi M
• Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
  The Journal of infectious diseases 2014 Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, Buchbinder SP, Hammer SM, Koblin…
• Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States.
  Journal of acquired immune deficiency syndromes (1999) 2014 Scott HM, Vittinghoff E, Irvin R, Sachdev D, Liu A, Gurwith M, Buchbinder SP
• Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
  PloS one 2013 Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman …
• No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.
  PloS one 2013 Marcus JL, Glidden DV, Mayer KH, Liu AY, Buchbinder SP, Amico KR, McMahan V, Kallas EG, Montoya-Herrera O, Pilotto J, Grant RM
• HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.
  Journal of clinical microbiology 2013 Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, …
• The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.
  International journal of STD & AIDS 2013 Volk JE, Hessol NA, Gray GE, Kublin JG, Churchyard GJ, Mlisana K, Nchabeleng M, Buchbinder SP, Bekker LG
• Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
  The New England journal of medicine 2013 Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, Adams E, DeJesus E, Novak RM, …
• Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.
  Journal of acquired immune deficiency syndromes (1999) 2013 Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, Collins BM, Pathak SR, O'hara B, Ackers ML, Rose CE, Grant RM, Paxton LA, Buchbinder SP
• Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States.
  Journal of acquired immune deficiency syndromes (1999) 2013 Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, Colfax G, Pathak S, Gvetadze R, O'hara B, Collins B, Ackers M, Paxton L, Buchbinder SP
• CROI 2013: New tools to understand transmission dynamics and prevent HIV infections.
  Topics in antiviral medicine 2013 Buchbinder SP, Liu AY
• What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)?
  PloS one 2012 Goodreau SM, Carnegie NB, Vittinghoff E, Lama JR, Sanchez J, Grinsztejn B, Koblin BA, Mayer KH, Buchbinder SP
• HIV incidence determination in the United States: a multiassay approach.
  The Journal of infectious diseases 2012 Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman …
• Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men.
  PloS one 2012 Vallabhaneni S, Li X, Vittinghoff E, Donnell D, Pilcher CD, Buchbinder SP
• Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis.
  Journal of acquired immune deficiency syndromes (1999) 2012 Volk JE, Liu A, Vittinghoff E, Irvin R, Kroboth E, Krakower D, Mimiaga MJ, Mayer KH, Sullivan PS, Buchbinder SP
• Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study.
  Journal of acquired immune deficiency syndromes (1999) 2012 Koblin BA, Mayer KH, Noonan E, Wang CY, Marmor M, Sanchez J, Brown SJ, Robertson MN, Buchbinder SP
• Antiretroviral use for prevention and other factors affecting the course of the HIV-1 epidemic.
  Topics in antiviral medicine 2012 Buchbinder SP
• Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trials.
  The Journal of infectious diseases 2012 Stephenson KE, Hural J, Buchbinder SP, Sinangil F, Barouch DH
• Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.
  PloS one 2012 Cheng C, Wang L, Wang L, Gall JG, Nason M, Schwartz RM, McElrath MJ, DeRosa SC, Hural J, Corey L, Buchbinder SP, Nabel GJ
• Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.
  The Journal of clinical investigation 2011 Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ
• Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection.
  PloS one 2011 Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Celum C, Buchbinder SP, Seage GR, Quinn TC, Donnell D, …
• Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia.
  PLoS genetics 2011 An P, Li R, Wang JM, Yoshimura T, Takahashi M, Samudralal R, O'Brien SJ, Phair J, Goedert JJ, Kirk GD, Troyer JL, Sezgin E, Buchbinder SP, Donfield S, Nelson GW, Winkler CA
• A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens.
  Statistical communications in infectious diseases 2011 Gilbert PB, Grove D, Gabriel E, Huang Y, Gray G, Hammer SM, Buchbinder SP, Kublin J, Corey L, Self SG
• Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.
  PloS one 2011 Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, Thompson M, Grant R, Pathak S, O'Hara B, Gvetadze R, Chillag K, Grohskopf L, Buchbinder SP
• Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study).
  Journal of acquired immune deficiency syndromes (1999) 2011 Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow R, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP, Corey L, NIAID HIV Vaccine Trials Network
• International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.
  Vaccine 2011 Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael …
• HIV epidemiology and breakthroughs in prevention 30 years into the AIDS epidemic.
  Topics in antiviral medicine 2011 Buchbinder SP
• Pre-exposure prophylaxis and the promise of combination prevention approaches.
  AIDS and behavior 2011 Buchbinder SP, Liu A
• Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women.
  AIDS (London, England) 2011 Delwart E, Bernardin F, Lee TH, Winkelman V, Liu C, Sheppard H, Liu A, Greenblatt R, Anastos K, DeHovitz J, Nowicki M, Cohen M, Golub ET, Barbour J, Buchbinder S, Busch MP, NIAID Center for HIV/AIDS …
• Male circumcision and risk of HIV acquisition among MSM.
  AIDS (London, England) 2011 Sánchez J, Sal Y Rosas VG, Hughes JP, Baeten JM, Fuchs J, Buchbinder SP, Koblin BA, Casapia M, Ortiz A, Celum C
• Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection.
  The Journal of infectious diseases 2010 Chinn LW, Tang M, Kessing BD, Lautenberger JA, Troyer JL, Malasky MJ, McIntosh C, Kirk GD, Wolinsky SM, Buchbinder SP, Gomperts ED, Goedert JJ, O'Brien SJ
• Lessons drawn from recent HIV vaccine efficacy trials.
  Journal of acquired immune deficiency syndromes (1999) 2010 Fuchs JD, Sobieszczyk ME, Hammer SM, Buchbinder SP
• Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
  The New England journal of medicine 2010 Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S…
• Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.
  PloS one 2010 Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, Troyer JL, O'Brien SJ
• Early versus deferred antiretroviral therapy for HIV.
  The New England journal of medicine 2009 Buchbinder SP, Jain V
• Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men.
  AIDS (London, England) 2009 Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D, Judson F, Koblin B, Mayer KH, Palefsky JM
• The epidemiology of new HIV infections and interventions to limit HIV transmission.
  Topics in HIV medicine : a publication of the International AIDS Society, USA 2009 Buchbinder S
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
  Lancet (London, England) 2008 Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN, Step Study…
• HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.
  Lancet (London, England) 2008 McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR, Step …
• Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level.
  Clinical and vaccine immunology : CVI 2008 Erickson AL, Willberg CB, McMahan V, Liu A, Buchbinder SP, Grohskopf LA, Grant RM, Nixon DF
• Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategies.
  Topics in HIV medicine : a publication of the International AIDS Society, USA 2008 Buchbinder S
• Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.
  Journal of acquired immune deficiency syndromes (1999) 2008 Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, Hecht J, Klausner JD, Buchbinder SP
• Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
  Journal of acquired immune deficiency syndromes (1999) 2007 Russell ND, Graham BS, Keefer MC, McElrath MJ, Self SG, Weinhold KJ, Montefiori DC, Ferrari G, Horton H, Tomaras GD, Gurunathan S, Baglyos L, Frey SE, Mulligan MJ, Harro CD, Buchbinder SP, Baden LR, …
• Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006 Morris SR, Klausner JD, Buchbinder SP, Wheeler SL, Koblin B, Coates T, Chesney M, Colfax GN
• Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION.
  Journal of acquired immune deficiency syndromes (1999) 2006 Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL
• Preexposure prophylaxis for HIV: unproven promise and potential pitfalls.
  JAMA 2006 Liu AY, Grant RM, Buchbinder SP
• AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
  Science (New York, N.Y.) 2005 Grant RM, Buchbinder S, Cates W, Clarke E, Coates T, Cohen MS, Delaney M, Flores G, Goicochea P, Gonsalves G, Harrington M, Lama JR, MacQueen KM, Moore JP, Peterson L, Sanchez J, Thompson M, Wainberg …
• New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid.
  Clinical chemistry 2005 Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J
• Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
  Journal of the National Cancer Institute 2005 Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, Palefsky JM
• Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States.
  Journal of acquired immune deficiency syndromes (1999) 2005 Buchbinder SP, Vittinghoff E, Heagerty PJ, Celum CL, Seage GR, Judson FN, McKirnan D, Mayer KH, Koblin BA
• Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study.
  The Journal of infectious diseases 2004 Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, Da Costa M, Darragh T, Hess E, Judson F, Koblin B, Madison M, Palefsky JM
• Alcohol use and high-risk sexual behavior among men who have sex with men: the effects of consumption level and partner type.
  Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2004 Vanable PA, McKirnan DJ, Buchbinder SP, Bartholow BN, Douglas JM, Judson FN, MacQueen KM
• Beliefs about HIV reinfection (superinfection) and sexual behavior among a diverse sample of HIV-positive men who have sex with men.
  Journal of acquired immune deficiency syndromes (1999) 2004 Colfax GN, Guzman R, Wheeler S, Mansergh G, Marks G, Rader M, Buchbinder SP
• Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.
  The Journal of infectious diseases 2004 Lee D, Graham BS, Chiu YL, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL
• Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation.
  Journal of acquired immune deficiency syndromes (1999) 2004 Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E
• Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
  AIDS (London, England) 2003 Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg…
• Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men.
  The Journal of infectious diseases 2003 Renzi C, Douglas JM, Foster M, Critchlow CW, Ashley-Morrow R, Buchbinder SP, Koblin BA, McKirnan DJ, Mayer KH, Celum CL
• Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion.
  AIDS (London, England) 2002 Colfax GN, Buchbinder SP, Cornelisse PG, Vittinghoff E, Mayer K, Celum C
• HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.
  Journal of acquired immune deficiency syndromes (1999) 2002 Sheppard HW, Celum C, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP
• Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic.
  JAMA 2002 Osmond DH, Buchbinder S, Cheng A, Graves A, Vittinghoff E, Cossen CK, Forghani B, Martin JN
• Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
  Annals of internal medicine 2001 Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, …
• Cofactors for HIV disease progression in a cohort of homosexual and bisexual men.
  Journal of acquired immune deficiency syndromes (1999) 2001 Vittinghoff E, Hessol NA, Bacchetti P, Fusaro RE, Holmberg SD, Buchbinder SP
• Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles.
  Journal of virology 2001 Day CL, Shea AK, Altfeld MA, Olson DP, Buchbinder SP, Hecht FM, Rosenberg ES, Walker BD, Kalams SA
• Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression.
  Journal of virology 2001 Islam SA, Hay CM, Hartman KE, He S, Shea AK, Trocha AK, Dynan MJ, Reshamwala N, Buchbinder SP, Basgoz NO, Kalams SA
• Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.
  American journal of epidemiology 2001 Seage GR, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP
• Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
  The Journal of infectious diseases 2000 Celum CL, Buchbinder SP, Donnell D, Douglas JM, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW
• Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations.
  AIDS education and prevention : official publication of the International Society for AIDS Education 2000 Gross M, Holte S, Seage GR, Buchbinder SP, Metzger DS, Mayer KH
• Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995.
  American journal of epidemiology 1999 Koblin BA, van Benthem BH, Buchbinder SP, Ren L, Vittinghoff E, Stevens CE, Coutinho RA, van Griensven GJ
• Use of reality "female condoms" for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team.
  American journal of public health 1999 Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas JM
• Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.
  Journal of virology 1999 Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, Shea AK, Trocha AK, Walker BD
• Combination antiretroviral therapy and incidence of AIDS-related malignancies.
  Journal of acquired immune deficiency syndromes (1999) 1999 Buchbinder SP, Holmberg SD, Scheer S, Colfax G, O'Malley P, Vittinghoff E
• Per-contact risk of human immunodeficiency virus transmission between male sexual partners.
  American journal of epidemiology 1999 Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP
• Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.
  The Journal of infectious diseases 1999 Bradney AP, Scheer S, Crawford JM, Buchbinder SP, Montefiori DC
• Correlates of condom failure in a sexually active cohort of men who have sex with men.
  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999 Stone E, Heagerty P, Vittinghoff E, Douglas JM, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR, Buchbinder SP
• Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
  The Journal of infectious diseases 1999 Vittinghoff E, Scheer S, O'Malley P, Colfax G, Holmberg SD, Buchbinder SP
• Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors.
  The Journal of infectious diseases 1998 Liegler TJ, Yonemoto W, Elbeik T, Vittinghoff E, Buchbinder SP, Greene WC
• Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team.
  Sexually transmitted diseases 1998 Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR
• Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.
  The Journal of clinical investigation 1998 Brander C, Hartman KE, Trocha AK, Jones NG, Johnson RP, Korber B, Wentworth P, Buchbinder SP, Wolinsky S, Walker BD, Kalams SA
• Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition.
  Journal of virology 1997 Wilson CC, Kalams SA, Wilkes BM, Ruhl DJ, Gao F, Hahn BH, Hanson IC, Luzuriaga K, Wolinsky S, Koup R, Buchbinder SP, Johnson RP, Walker BD
• Insurance type and satisfaction with medical care among HIV-infected men.
  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997 Katz MH, Marx R, Douglas JM, Bolan GA, Park MS, Gurley RJ, Buchbinder SP
• Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990.
  American journal of epidemiology 1996 Koblin BA, Hessol NA, Zauber AG, Taylor PE, Buchbinder SP, Katz MH, Stevens CE
• Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate.
  The Journal of infectious diseases 1996 Buchbinder SP, Douglas JM, McKirnan DJ, Judson FN, Katz MH, MacQueen KM
• Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
  Science (New York, N.Y.) 1996 Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ
• The association between cigarette smoking and selected HIV-related medical conditions.
  AIDS (London, England) 1996 Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD
• Depression and use of mental health services among HIV-infected men.
  AIDS care 1996 Katz MH, Douglas JM, Bolan GA, Marx R, Sweat M, Park MS, Buchbinder SP
• Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.
  AIDS research and human retroviruses 1996 Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD
• Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
  Journal of immunology (Baltimore, Md. : 1950) 1996 Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD
• T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
  The Journal of experimental medicine 1996 Kalams SA, Johnson RP, Dynan MJ, Hartman KE, Harrer T, Harrer E, Trocha AK, Blattner WA, Buchbinder SP, Walker BD
• Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials.
  AIDS & public policy journal 1996 MacQueen KM, Buchbinder SP, Douglas JM, Judson FN, McKirnan DJ, Bartholow BN
• The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus.
  American journal of epidemiology 1995 Holmberg SD, Buchbinder SP, Conley LJ, Wong LC, Katz MH, Penley KA, Hershow RC, Judson FN
• Health insurance and use of medical services by men infected with HIV.
  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995 Katz MH, Chang SW, Buchbinder SP, Hessol NA, O'Malley P, Doll LS
• Hepatitis C virus infection in sexually active homosexual men.
  The Journal of infection 1994 Buchbinder SP, Katz MH, Hessol NA, Liu J, O'Malley PM, Alter MJ
• Long-term HIV-1 infection without immunologic progression.
  AIDS (London, England) 1994 Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD
• Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS.
  The Journal of infectious diseases 1994 Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD
• Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.
  American journal of epidemiology 1994 Hessol NA, Koblin BA, van Griensven GJ, Bacchetti P, Liu JY, Stevens CE, Coutinho RA, Buchbinder SP, Katz MH
• Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.
  AIDS (London, England) 1994 Lifson AR, Hilton JF, Westenhouse JL, Canchola AJ, Samuel MC, Katz MH, Buchbinder SP, Hessol NA, Osmond DH, Shiboski S
• Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
  AIDS (London, England) 1993 Holmberg SD, Conley LJ, Buchbinder SP, Judson FN, Bush TJ, Katz MH, Penley KA, Hershow RC
• Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990.
  American journal of epidemiology 1993 van Griensven GJ, Hessol NA, Koblin BA, Byers RH, O'Malley PM, Albercht-van Lent N, Buchbinder SP, Taylor PE, Stevens CE, Coutinho RA
• Use of Bayes theorem to estimate the impact of the proposed CD4-based expansion of the AIDS case definition.
  Journal of acquired immune deficiency syndromes 1993 Katz MH, Hessol NA, Buchbinder SP, Mebane WR, O'Malley P, Lemp GF, Holmberg SD
• Herpes zoster and human immunodeficiency virus infection.
  The Journal of infectious diseases 1992 Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, Holmberg SD
• Increased incidence of Hodgkin disease in homosexual men with HIV infection.
  Annals of internal medicine 1992 Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD
• Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.
  Lancet (London, England) 1992 Lifson AR, Hessol NA, Buchbinder SP, O'Malley PM, Barnhart L, Segal M, Katz MH, Holmberg SD
• Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates.
  American journal of public health 1992 Hessol NA, Buchbinder SP, Colbert D, Scheer S, Underwood R, Barnhart JL, O'Malley PM, Doll LS, Lifson AR
• Predictors of HIV disease progression in the era of prophylactic therapies.
  AIDS clinical review 1992 Hessol NA, Buchbinder SP
• Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis.
  AIDS (London, England) 1992 Katz MH, Greenspan D, Westenhouse J, Hessol NA, Buchbinder SP, Lifson AR, Shiboski S, Osmond D, Moss A, Samuel M
• The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS.
  AIDS (London, England) 1991 Lifson AR, Hessol NA, Buchbinder SP, Holmberg SD
• Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.
  The Journal of infectious diseases 1991 Lifson AR, Buchbinder SP, Sheppard HW, Mawle AC, Wilber JC, Stanley M, Hart CE, Hessol NA, Holmberg SD
• The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts.
  AIDS (London, England) 1991 Feigal DW, Katz MH, Greenspan D, Westenhouse J, Winkelstein W, Lang W, Samuel M, Buchbinder SP, Hessol NA, Lifson AR
• HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices.
  American journal of public health 1990 Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Rutherford GW
• Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.
  BMJ (Clinical research ed.) 1990 Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, Barnhart JL, Bodecker TW, Cannon L, Doll LS